RecruitingNot ApplicableNCT04971850

Sleep-disordered Breathing and Neurocognitive Assessment in Children and Young Adults

Sleep-Disordered Breathing and Neurocognitive Assessment in Children and Young Adults


Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

1,200 participants

Start Date

Feb 2, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

One of main problems in the management of sleep-disordered breathing (SDB) in children and young adults is their screening, and the absence or the weak correlation between clinical symptoms and polysomnography (PSG). It may be useful to use additional measures together with PSG to improve the detection and characterization of respiratory events during sleep and/or correlation with clinical signs of SDB. The primary objective of the study is to determine whether psychological and neuropsychological test scores correlate with diagnostic PSG results.


Eligibility

Min Age: 1 YearMax Age: 20 Years

Inclusion Criteria2

  • Patients aged 1 to 20 years with a suspicion of SDB or a high-risk of SDB due to their pathology and hospitalized at Necker Hospital for a sleep study
  • Written informed consent

Exclusion Criteria6

  • No social insurance
  • Significant psychomotor retardation
  • Cooperation not possible
  • Significant agitation
  • Acute condition and/or temporary drug treatments that may interfere with the results of PSG (upper or lower airway infection)
  • Patient under guardianship/curatorship

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSleep study

Procedures added by research during PSG : * SDB screening questionnaires * Electromyography (EMG) of accessory and abdominal muscles * Cerebral oxygenation * Mandibular movements * Sleep headband (pre-teens and teens) or other connected device * Automatic PSG analyzes * Psychological and neuropsychological assessment The recordings of the study will be repeated at one year if the patient needs a treatment (surgery or noninvasive ventilation) following the results of the PSG.


Locations(1)

Hôpital Necker-Enfants Malades

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04971850


Related Trials